Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells
在肝细胞癌细胞对索拉非尼产生耐药性后，Akt 和 c-Met 双重抑制可作为二线治疗方案。
期刊:Molecular Oncology
影响因子:4.5
doi:10.1002/1878-0261.12039
Han, Peng; Li, Hali; Jiang, Xian; Zhai, Bo; Tan, Gang; Zhao, Dali; Qiao, Haiquan; Liu, Bing; Jiang, Hongchi; Sun, Xueying
